| ∆8-THC | ∆8-tetrahydrocannabinol |
| ∆9-THC | ∆9-tetrahydrocannabinol |
| 2-AG | 2-arachidonylglycerol |
| 5-HT | serotonin receptor |
| ACE2 | angiotensin-converting enzyme 2 |
| AChE | acetylcholinesterase |
| AEA | anandamide |
| AIDS | acquired immune deficiency syndrome |
| cAMP | cyclic adenosine monophosphate |
| CB1 | cannabinoid receptor type 1 |
| CB2 | cannabinoid receptor type 2 |
| CBC | cannabichromene |
| CBD | cannabidiol |
| CBDA | cannabidiolic acid |
| CBDV | cannabidivarin |
| CBE | cannabielsoin |
| CBG | cannabigerol |
| CBGA | cannabigerolic acid |
| CBGV | cannabigerovarin |
| CBL | cannabicycline |
| CBN | cannabinol |
| CBNA | cannabinoic acid |
| CBND | cannabinodiol |
| CBT | cannabitriol |
| CDAI | Crohn’s disease activity index |
| CINV | chemotherapy-induced nausea and vomiting |
| CoA | coenzyme A |
| COVID-19 | coronavirus disease 2019 |
| CRP | C-reactive protein |
| CSG | Coronavirus Study Group |
| CXCL10/IP10 CYP |
CXC-chemokine ligand cytochrome P450 |
| DMAPP | dimethylallyl diphosphate |
| DS | Dravet syndrome |
| FAAH | fatty acid amide hydrolase |
| FiO2 | fraction of inspired oxygen |
| FPP | farnesyl diphosphate |
| GABA | γ-aminobutyric acid |
| GPP | geranyl diphosphate |
| GPR | G protein-coupled receptor |
| G-SCF | granulocyte colony-stimulating factor |
| IBD | inflammatory bowel disease |
| IL | interleukin |
| IPP | isopentenyl diphosphate |
| LD50 LGS |
median lethal dose Lennox-Gastaut syndrome |
| MCP1/CCL2 | monocyte chemoattractant protein-1 |
| MEP | plastidic methylerythritol phosphate |
| MIP1-α/CCL3 | macrophage inflammatory protein 1 alpha |
| MVA | mevalonic acid |
| PPAR | peroxisome proliferator-activated receptor |
| ROS | reactive oxygen species |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| SM | sclerosis multiplex |
| SpO2 Th1 |
blood oxygen saturation T-helper type 1 |
| THC | tetrahydrocannabinol |
| THCA | tetrahydrocannabinolic acid |
| TMPRSS2 | transmembrane serine protease 2 |
| TNF-α | tumor necrosis factor |
| TRP TRPM |
transient receptor potential channels transient receptor potential melastatin |
| TRPV1 | transient potential type 1 vanilloid receptor |
| TSC | tuberous sclerosis syndrome |
| USP | Pharmacopoeia of the United States |
| WHO | World Health Organization |